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Abstract
Background: The characteristics of cervical lymphatic metastasis in nasopharyngeal carcinoma (NPC) are not
completely understood. As such, radiotherapy to the entire lymphatic of the neck bilaterally has been empirically
practiced even in early stage disease, although not supported by clinical evidence. We studied the pattern and
probability of nodal metastasis through a meta-analysis of published evidences, with an aim to establish an
evidence-based guideline for selecting and delineation of clinical target volume of neck lymphatics for
conformation radiation for NPC.
Methods: A literature search yielded an initial 411 original articles, and 13 studies with 2920 NPC cases staged via
MRI were included in this analysis. The occurrence of nodal metastasis was calculated and analyzed according to
the respective regional nodal levels.
Results: 85% of NPC cases presented with lymphadenopathy. The most commonly involved regions include
retropharyngeal (69%) and level II lymph nodes (70%). The overall probability of levels III, IV, and V nodal
involvement are 45%, 11%, and 27%, respectively. Low-risk node groups included the supraclavicular, levels IA/IB
and VI nodes, and parotid nodes with involvement rates at 3%, 0%, 3%, 0%, and 1%, respectively. Nodal metastases
followed an orderly pattern and the probability of “skip” metastasis between levels varied between 0.5-7.9%.
Conclusions: Lymph node metastasis in NPC follows a predictable and orderly pattern. The rarity of metastasis in
certain nodal groups and “skip” metastasis suggest that reduced treatment volume is feasible in conformal
radiotherapy for NPC.
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Background
Nasopharyngeal carcinoma (NPC) is the most com-
monly diagnosed head and neck cancer in Southeast
Asia, with a reported annual incidence of 30-80 per 105
population in endemic regions [1]. Like most other
squamous cell carcinomas (SCC) of the head and neck
primaries, lymphatic drainage of the nasopharynx is pre-
dominantly to the cervical lymph nodes. However, NPC
has the highest preponderance for regional lymph node
metastasis among head and neck SCC [2]. Radiation has
been the mainstay of definitive treatment for NPC. The
fields of radiation therapy for NPC traditionally encom-
pass the primary disease and involved neck nodes, as
well as the entire draining lymphatic regions to the
lower neck. In a retrospective study reported by Lee et
al, 57 (30%) of the 189 patients who did not receive
elective neck irradiation subsequently developed cervical
lymph node recurrence. However, none of the seven
regionally treated patients relapsed [3]. Results from this
and other similar studies have led to the practice of
empirical irradiation of the entire neck in treating NPC,
[4] regardless of the stage of NPC at diagnosis.
However, treatment of a large field to the neck is
associated with substantial morbidities, both early and
late: Early toxicities include brisk radiation dermatitis
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and odynophagia, especially if concurrent chemo-radia-
tion is utilized; late toxicities may include neck fibrosis,
lymphedema, brachial plexopathy, and thyroid dysfunc-
tion [5]. The therapeutic ratio may be maintained or
improved if selective neck irradiation can be safely
implemented in patients with limited nodal disease bur-
den. Such practice may improve the tolerability of radia-
tion therapy, as well as the compliance and quality of
life of the patients.
A more accurate definition of target volume of regio-
nal lymph node region in radiation therapy also
becomes possible because of the significant improve-
ments made in imaging technology. Compared to com-
puted tomography (CT), magnetic resonance imaging
(MRI) has improved soft tissue contrast and multi-pla-
nar capability [6]. MRI scans have been shown to be
particularly useful in the assessment of retropharyngeal
and cervical lymphadenopathy [7]. Ng et al found that
the nodal status was changed from negative on CT to
positive on MRI in 4 of 67 patients (6%). This led them
to conclude that MRI allows more accurate evaluation
of the extent of NPC than CT and should be the pri-
mary mode of investigation [8]. Sakata et al also showed
that MR was better than CT at identifying metastases to
lymph nodes in the carotid and retropharyngeal spaces,
with significant prognostic implications [9]. Liao et al
demonstrated a significant difference between CT and
MRI in demonstrating involvement in the retropharyn-
geal lymph nodes (CT, 52.1% vs. MRI, 69.0%). MRI
resulted in changes in 10.7% of N stage cases and 38.6%
of clinical stage cases [6]. A small study involving
patients suspected of having NPC has demonstrated that
MRI had a sensitivity of 100%, specificity of 95%, nega-
tive predictive value of 100%, positive predictive value of
43%, and an overall accuracy of 95% when verified with
biopsy. (AJNR Am J Neuroradiol. 2006 Jun-Jul;27
(6):1288-91. Magnetic resonance imaging for the detec-
tion of nasopharyngeal carcinoma. King AD, Vlantis AC,
Tsang RK, Gary TM, Au AK, Chan CY, Kok SY, Kwok
WT, Lui HK, Ahuja AT) On the basis that MRI has a
high overall accuracy rate, possesses good imaging char-
acteristics, and is the current standard of care, we
choose to focus our efforts on MRI for this study.
Advances in radiation therapy, including image gui-
dance and intensity-modulated radiation therapy (IMRT),
have also allowed oncologists to be highly selective and
accurate in treatment delivery. In the IMRT era, it is
often up to the clinical judgment of the radiation oncolo-
gist to decide how much of the neck to irradiate and to
what dose [10]. While a standardized atlas [11] is already
in routine clinical use for the delineation clinical target
volumes in the neck, there is currently no consensus as
to the optimal volume for elective irradiation of the neck
for NPC, especially for patients with node negative
disease.
Several authors have described the pattern of nodal
metastases in NPC,[2,12,13] with a common view that
cervical node metastases appear to occur in an orderly
fashion with infrequent skip metastases. However, the
actual distribution of nodal metastases as described in
terms of lymph node levels differs between studies. Addi-
tionally, the reported rate of “skip” metastases varies
between studies, ranging from 0.5% to 7.9% [14,15]. As
such, we embarked on this review to examine the pattern
and probability of regional node metastasis through a
systematic analysis of published evidence using MRI for
diagnosis and staging of NPC. Additionally, we sought to
identify low risk regional node groups in NPC, thereby
providing an evidence-based proposal for lymphatic tar-
get selection in conformal radiation therapy for NPC.
Methods
Search strategy and eligibility criteria
A systematic review of original articles and abstracts ana-
lyzing the cervical nodal metastasis status of patients with
NPC was performed by searching electronic databases
PUBMED (January 1990 to December 2009), CANCERLIT
(January 1990 to December 2009), and the Cochrane
Library (January 1980 to July 2007). Studies were eligible if
the cervical and/or retropharyngeal node positivity rate in
NPC was reported. Search strategy included the following
keywords in various combinations: “nasopharyngeal
cancer”, “lymph nodes”, “nasopharyngeal carcinoma”,
“lymphatic metastasis”, “cervical nodes”, and “retropharyn-
geal nodes”. Searches were supplemented by scanning bib-
liographies and references of included articles. The titles
and abstracts of articles retrieved by this search were eval-
uated against inclusion criteria, and the manuscripts of all
studies deemed potentially eligible were obtained.
The imaging modality used had to be predominantly
or exclusively magnetic resonance imaging. Studies
using CT only were excluded. There was no restriction
criterion on the number of patients enrolled in the
study. Given the volume of articles retrieved, articles
were limited to English only. As there were overlapping
and duplicate data sets detected on the same series of
patients, only the most recent or most informative study
was included in the analysis after checking with the
respective authors.
Data extraction
Two investigators, namely the first and the last author,
independently extracted data from selected articles,
including year of publication, first author, reported ret-
ropharyngeal and cervical LN positive rate in NPC
patients at the respective nodal stations as and when
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available. To ensure the accuracy of this process and to
minimize subjective judgment, all data were verified
between the two reviewers, and discrepancies were
settled through consensus discussion. Two participants
of this analysis examined the accuracy of the data from
each individual publication.
Multiple criteria were used to determine metastatic
lymph node involvement, namely, central necrosis, extra
capsular spread, shortest diameter of cervical or medial
retropharyngeal lymph nodes > 1 cm and > 5 mm for lat-
eral retropharyngeal lymph node(s). The occurrence of
LN metastasis (retrospectively classified according to
DAHANCA, EORTC, GORTEC, NCIC, RTOG consen-
sus guidelines as far as possible) was calculated and ana-
lyzed according to the respective regional lymph nodal
stations [11]. Studies where nodal stations could not be
retrospectively classified were excluded from this meta-
analysis. The incidence of disease involvement of all
regional lymph nodal regions (according to RTOG classi-
fication) was the primary outcome. In this way, pooled
analyses of the incidence of metastasis to regional lymph
nodes were calculated and reported.
Data analysis
Statistical analyses were performed using Stata® software,
version 10.2 (Stata Corp College Station, TX, USA). Pub-
lication bias for the primary endpoint was assessed via
construction of a Begg’s funnel plot, as well as by the
Begg and Mazumdar adjusted rank correlation method
[16]. Meta-analysis for the regional node metastasis in
NPC was performed by calculating pooled estimates of
proportion. Lymph node metastasis positive rate was the
primary outcome. Using the Cochran Q Statistic, we
assessed inter-study heterogeneity. This is calculated as
the weighted sum of squared differences between indivi-
dual study effects and the pooled effect across studies,
with the weights being those used in the pooling method
[17]. Because studies were found to be heterogeneous,
proportion of patients with positive LN metastasis for the
respective nodal station with corresponding 95% confi-
dence intervals (CIs) were calculated using random-
effects modeling after DerSimonian and Laird [18]. The
CIs were calculated using formulae for proportion. Stu-
dies were weighted using random effects analysis. The
weightage of each study was a combination of sample
size (i.e. within study variation) and between study
variations.
Results
Characteristics of included studies
The initial literature search resulted in 411 citations
using the data extraction methods as described above.
The title and abstract of each retrieved publication were
reviewed to confirm that the article reported on the
incidence of lymph node involvement in patients with
NPC. In the event that this approach was not informa-
tive, the full article was retrieved and reviewed in detail.
This process resulted in excluding 379 studies and 33
studies were selected. Of these 33 studies, the main
modality of imaging was MRI in 19 studies, CT in 13
studies and PET in 2 studies. Out of the 19 articles
focusing on MRI, four were non-English articles and
were excluded. Two articles from Wang et al were
found to have overlapping data after verifying with the
original author; the more relevant paper of the two was
chosen [19]. One article by Liao et al was excluded as
the incidence of node metastasis was described as the
total no of positive lymph nodes in the population as
opposed to other papers, which described the number
of patients with positive lymph nodes at the respective
nodal stations [6].
Figure 1 demonstrates the Begg’s Funnel Plot assessing
the publication bias for the proportion of patients with
any nodal metastases in 11 studies. Only 11 studies out of
the 13 studies were included in this plot, as the remaining
two studies did not include relevant data for patients pre-
senting with any lymphadenopathy. The funnel plot shows
that a few points fall outside the funnel, but they are both
above and below the funnel, hence indicating no clear
direction in the bias, and a formal Egger test also indicates
that there is no significant publication bias (p = 0.143).
Consequently, thirteen original research reports (as
listed in Table 1 below) and a total of 2920 NPC cases
evaluated with MRI were included in this analysis
[7,8,12-14,19-26]. Three out of 13 studies were prospective
studies, while the rest were retrospective studies that had
looked at consecutive patients [12,23,25]. The patients
were diagnosed with NPC between 1990 and 2006. The
mean number of patients per study was 224 with a range
of 63 patients to 924 patients.
In studies that provided baseline demographic informa-
tion on NPC patients, a total of 2101 were men and 702
were women [7,8,12-14,19-26]. The mean age was
reported in 4 studies and ranged between 47.8 years and
49.3 years,[7,8,12,23] and the reported median age ranged
from 45 years to 51 years in 6 studies [14,20-22,25,26]. In
the seven studies that provided data on the histological
subtypes of the patients, most patients had either WHO
type II or III NPC. This ranged from 82% to 100%, with
type III being more common [7,13,14,19-21,26]. Other
histological subtypes like adenocarcinoma were rarely
reported [14]. Of the six studies that looked at cervical
LN metastasis specifically, all utilized all of the criteria
for nodal involvement detailed above [7,12-14,19,20].
The LN location was classified either according to the
consensus guidelines [11] or the “Level” system by Som
et al. [27] The only major differences between these two
guidelines lie in their classification of supraclavicular
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nodes. This may explain why the studies using the Som
classification demonstrated a much higher rate of supra-
clavicular nodes involvement at more than 15%[12,20]
compared to the studies that used the consensus guide-
lines, which reported rates of approximately 3% [13,14].
Hence the data for supraclavicular LN involvement in
this meta-analysis has to be interpreted with caution.
Results by lymph node levels
Collectively, 84.9% of NPC cases presented with regional
lymphadenopathy. Metastases to neck nodes follow an
orderly pattern and the probability of “skip” metastasis
between regional nodes vary from 0.5% to 7.9%. Figure 2
summarizes the key findings by nodal levels. Broadly
speaking, the nodal stations may be divided into high,
intermediate and low risk echelons. The two most com-
monly involved regions at staging were the RLN (69.4%)
and level II LN (70.4%). These stations probably repre-
sent the first echelon nodes draining the nasopharynx.
Overall probability of levels III, IV, and V nodal involve-
ment are 44.9%, 11.2%, and 26.7%, respectively. These
stations are likely to represent the 2nd echelon of draining
Figure 1 Begg’s Funnel Plot assessing publication bias for the proportion of patients presenting with any LN metastasis in 11
relevant studies. Yellow dots represent the 11 relevant studies. Y axis is the proportion of patients in the particular study presenting with any
lymph node metastasis. X axis is the standard error of this proportion of interest.

























1 Tang 924 786 679 24 590 226 56 87 6 31
2 Wang 618 543 508 392 508 21 506 237 72 200 7
3 Liu 275 215 175 175 175 174 65 16 18 4 8
4 King 150 115 115 108 115 3 66 2
5 Ng 202 193 162 190 172 22 31
6 Fuwa 94 82 82 82
7 Ng 101 89 73 2 85 54 31 24 2 3 20
8 Lu 159 148 139 108 139
9 Lam 44 39 13
10 Chong 114 91 58 59 58
11 Ng 67 42 39 42
12 Kam 63 44 44 44
13 Wolden 109 90 90 90
Abbreviations: LN, lymph nodes; RLN, Retropharyngal LN; SCF, supraclavicular fossa.
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nodes in NPC. The 3rd echelon of draining nodes in NPC
include the supraclavicular, levels IA, IB, and VI nodes,
as well as parotid LN, with a rate of involvement at 8.8%
(3% if classified according to the consensus guidelines),
0%, 2.7%, 2%, and 0.9% respectively. These likely repre-
sent the low risk nodal groups in NPC. Figure 3 and 4
shows meta-analysis plots for lymph node involvement in
general and in the cervical region, respectively. Figures 5
and 6 demonstrate meta-analysis plots for the retrophar-
yngeal lymph nodes and level II cervical lymph nodes,
which fall into the high risk nodal stations. Figures 7, 8
and 9 demonstrate meta-analysis plots for the level III,
level V & level IV cervical lymph nodes, the intermediate
risk nodal stations. Figures 10, 11, 12 and 13 demonstrate
meta-analysis plots for the supraclavicular, level Ib, level
VI & parotid lymph nodes which then fall into the low
risk nodal stations. Finally, Figure 14 illustrates the sum-
mary incidence rates of nodal metastases for the different
levels. There were no patients with positive level Ia cervi-
cal lymph nodes, hence the absence of a meta-analysis
plot for this group.
Discussion
Summary of results
Nasopharyngeal cancer (NPC) has a high propensity of
cervical node metastasis. The results of this meta-ana-
lysis based on 13 clinical trials using MRI for diagnosis
and staging for NPC revealed that the most commonly
involved cervical lymph node regions include lateral
retropharyngeal nodes and level II nodes with an
overall probability of 69.4% & 70.4% respectively for
metastasis. These first echelon nodal groups are fol-
lowed by levels III, VA, and IV, with probabilities of
44.9%, 26.7%, 11.2%, respectively. Certain cervical
lymph node groups, including level I, level VI, parotid
and supraclavicular nodes have a very low risk for
metastasis. An important finding was that lymphatic
spread in cervical nodal chain from NPC primary fol-
lows an orderly fashion. There was a very low risk of
0.5% in skip nodal metastasis [14].
These findings are important for the management of
NPC, particularly in defining proper treatment fields for
definitive radiation therapy using conformal technology
such as intensity-modulated radiation therapy (IMRT).
As the subclinical involvement of cervical lymph nodes
cannot be reliably detected by image studies including
CT, MRI, and/or PET/CT, proper selection and delinea-
tion of clinical target volume for elective irradiation
represents a major challenge. Bilateral cervical lymph
node metastases usually occur in the early phase of dis-
ease development. Therefore, irradiation of the entire
cervical lymphatic draining region has been a common
practice in radiotherapy of NPC, including stage I dis-
ease,[3,28,29] with radiation portals encompassing all
levels of cervical lymph nodes from IB to V, including
the supraclavicular region [30]. Despite improved out-
comes in terms of locoregional control and disease-free
survival rates with IMRT,[31,32] such a treatment strat-
egy might represent over-treatment using the current
diagnostic and therapeutic technology. NPC patients who
Figure 2 Graphical representation of results divided into respective lymph node echelons and risk groups. The X axis percentages
represent the percentage of nodal involvement at the respective level.
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Figure 3 Meta-analysis plot for patients with any LN metastasis. This is the forest plot generated from the 11 studies that contained
relevant data. Notice study 9 and 11 are missing as these 2 studies did not contain data specifying they looked at both retropharyngeal lymph
nodes and cervical lymph nodes. The 1st column specifies the study set used. The second column specified the proportion of patients that
presented with lymph node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-
analysis. The X axis represents the proportion of patients who present with any nodal involvement.
Figure 4 Meta-analysis plot for patients with any cervical LN metastasis. This is the forest plot generated from the 9 studies that contained
relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented with lymph
node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X axis
represents the proportion of patients who present with any cervical LN involvement.
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are cured of their disease may suffer from the long-term
complications from treatment,[5] including xerostomia,
neck fibrosis, telangiectasia, thyroid dysfunction, brachial
plexopathy and second malignancies, which can
significantly impact on function, quality of life or life
expectancy. While some of these side effects have been
minimized with the advent of conformal radiotherapy,
they cannot be fully prevented, especially if the nodal
Figure 5 Meta-analysis plot for patients with RLN metastasis. This is the forest plot generated from the 10 studies that contained relevant
data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented with lymph node
metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X axis represents
the proportion of patients who present with any RLN involvement.
Figure 6 Meta-analysis plot for patients with Level II cervical LN metastasis. This is the forest plot generated from the 6 studies that
contained relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented
with lymph node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X
axis represents the proportion of patients who present with any Level II cervical involvement.
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clinical target volumes are adjacent to the critical
structures.
An effective strategy in reducing treatment-induced
morbidity is to minimize the field for elective radiation in
the uninvolved neck region. In a recently reported study
by Lin et al, exclusion of level Ib lymph nodes and supra-
clavicular region for elective treatment in IMRT for
locoregionally advanced NPC did not reduce the prob-
ability of regional control rate as compared to historic
controls [33]. Furthermore, in a recently published study
of more than 400 NPC patients with N0 disease who
were treated with definitive dose of radiation to the pri-
mary and upper neck fields (levels II, III, and Va) only,
recurrence out of the radiation field at the level IV neck
Figure 7 Meta-analysis plot for patients with Level III cervical LN metastasis. This is the forest plot generated from the 5 studies that
contained relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented
with lymph node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X
axis represents the proportion of patients who present with any Level III cervical involvement.
Figure 8 Meta-analysis plot for patients with Level V cervical LN metastasis. This is the forest plot generated from the 6 studies that
contained relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented
with lymph node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X
axis represents the proportion of patients who present with any Level V cervical involvement.
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region and supraclavicular area occurred in only one
patient [34]. A similar retrospective review of 924 NPC
patients with N0 disease compared the inferior border of
radiotherapy either at the cricoid cartilage or below the
cricoid cartilage revealed no statistically significant differ-
ence between the two groups [14]. The use of MRI in the
diagnosis and staging and/or more advanced treatment
strategies including IMRT and concurrent chemoradia-
tion therapy might play substantial roles for the
aforementioned findings. However, the optimal strategy
of selection and delineation of the sub clinical regional
disease in clinical target volume (CTV) in the treatment
of NPC has not been well addressed. Knowledge on
regional lymph node drainage in NPC diagnosed and
staged in the modern era particular with MRI is limited,
and the current available data are usually not complete
with inconsistent results. More systemic and comprehen-
sive understanding of the patterns of cervical nodal
Figure 9 Meta-analysis plot for patients with Level IV cervical LN metastasis. This is the forest plot generated from the 5 studies that
contained relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented
with lymph node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X
axis represents the proportion of patients who present with any Level IV cervical involvement.
Figure 10 Meta-analysis plot for patients with SCF LN metastasis. This is the forest plot generated from the 4 studies that contained
relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented with lymph
node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X axis
represents the proportion of patients who present with any SCF LN involvement.
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involvement in NPC is clearly necessary for proper
design of clinical trials using conformal radiation techni-
ques and will provide practice-changing clinical evidence.
Although our results represented the most compre-
hensive and conclusive data for the pattern and prob-
ability of cervical lymph node spread in NPC, a number
of issues related to the design and analyses need to be
addressed. As radiation therapy is the only curative
treatment currently, and surgery including neck dissec-
tion has a limited role in the primary treatment for
NPC, adenopathy is universally diagnosed by imaging
studies. Histological diagnosis for cervical node metasta-
sis is rarely performed. The radiology diagnosis of cervi-
cal lymph adenopathy is largely based on size and
morphology criteria [35] derived from surgical series.
Prior to the use of MRI for staging and diagnosis, NPC
was usually evaluated using contrast enhanced CT to
assess the extent of disease in both primary and neck
regions [36]. Most of the available data on neck node
involvement and its treatment are based on CT imaging.
Figure 11 Meta-analysis plot for patients with Level IB cervical LN metastasis. This is the forest plot generated from the 4 studies that
contained relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented
with lymph node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X
axis represents the proportion of patients who present with any Level IB cervical involvement.
Figure 12 Meta-analysis plot for patients with Level VI cervical LN metastasis. This is the forest plot generated from the 3 studies that
contained relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented
with lymph node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X
axis represents the proportion of patients who present with any Level VI cervical involvement.
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However, the sensitivity and specificity rates of
enhanced CT for the diagnosis of cervical lymph adeno-
pathy are approximately 14-60% and 78-92% respec-
tively, compared to 29-80% and 82-92% respectively for
MRI [35]. The benefit of MRI over CT in evaluating
cervical lymph nodes for NPC has also been recently
reported [37]. Additionally, a meta-analysis has shown
that the accuracy of MRI appears superior to PET-CT
in the evaluation of cervical lymphadenopathy [38].
Accordingly, the updated 7th edition of the TNM Classi-
fication of Malignant Tumours [39] proposes that MRI
should be considered the standard imaging modality for
the diagnosis and staging of NPC.
In addition, a locally advanced tumor in the nasophar-
ynx obviously would have a higher probability of cervi-
cal lymph node metastasis as compared to early stage
disease. The knowledge of the exact NPC stage of each
study subject could provide valuable insight as to how
nodal metastasis changes with staging of the tumor.
Unfortunately, this information was not readily available
for such analyses.
One of the greatest challenges in performing this meta-
analysis was the weighting of the individual studies. The
studies were highly heterogeneous in their study design
from prospective to retrospective (predominant). Many
of them were not designed to study regional nodal metas-
tasis as the main end point but were included due to the
paucity of such data in the MRI era. As such, the usual
Figure 13 Meta-analysis plot for patients with parotid LN metastasis. This is the forest plot generated from the 5 studies that contained
relevant data. The 1st column specifies the study set used. The second column specified the proportion of patients that presented with lymph
node metastasis in the particular study. The last column states the weightage of each study contributing to the meta-analysis. The X axis
represents the proportion of patients who present with any parotid LN involvement.
Figure 14 Pictorial summary of incidence of LN metastasis in
NPC. This is a pictorial representation of the neck. The respective
numbers represent the overall percentage of NPC patients
presenting with positive LN metastasis at the particular nodal
station.
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criteria for weighting studies in systematic reviews could
not be applied to this study [40,41].
Conclusion
This meta-analysis provides some grounds to potentially
reduce treatment volume in NPC patients diagnosed
and staged using MRI and treated with modern radio-
therapy technology such as IMRT. However, clinical stu-
dies are required before this volume reduction can be
adopted as standard of care. According to our results,
we hypothesize that limiting coverage to the retrophar-
yngeal, levels II, III, and Va nodes in patients with N0
disease or on the uninvolved neck in patients with N1
disease would not compromise regional control rates
and disease-free survival. Furthermore, the rarity of skip
metastasis in NPC lymphatic drainage provides a basis
to eliminate irradiation to the entire involved side of the
neck, and only encompass the echelon inferior to the
involved level. This hypothesis will be tested in a newly
designed multi-center prospective clinical trial initiated
at our institute.
Abbreviations
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